T39.92 Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm

Name of the Condition

• Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm (ICD-10 Code: T39.92)

Summary

This condition involves intentional self-harm through poisoning by nonopioid analgesics, antipyretics, or antirheumatics when the specific agent is not identified. These medications are commonly used for pain relief, fever reduction, or inflammation management. The code applies to cases where the substance caused harm due to deliberate self-inflicted exposure, with the exact agent unspecified.

Causes

Intentional self-harm poisoning may result from deliberate overdose or ingestion of these medications. The unspecified nature of the agent means the exact substance is not documented, but the intent is confirmed as self-harm. Common scenarios include intentional ingestion of multiple doses or mixing medications with the intent to cause harm.

Risk Factors

• Risk factors include mental health conditions (e.g., depression, anxiety), history of self-harm, access to medications, and social or environmental stressors. Individuals with a history of substance use or suicidal ideation may be at increased risk.

Symptoms

• Symptoms vary by substance but may include nausea, vomiting, abdominal pain, dizziness, confusion, or respiratory distress. Severe cases can lead to organ damage, depending on the specific drug involved.

Diagnosis

Diagnosis relies on clinical assessment, patient history (including intent), and laboratory testing to identify the presence of toxic substances. Documentation of self-harm intent is critical for accurate coding. Physical examination and toxicology screens help confirm exposure and guide management.

Treatment Options

Treatment focuses on stabilizing the patient, removing the toxin (e.g., activated charcoal), and managing symptoms. Supportive care, such as intravenous fluids or monitoring of organ function, may be necessary. Psychiatric evaluation and intervention are essential to address the underlying intent.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and the patient’s overall health. Follow-up includes monitoring for complications, reassessment of mental health, and coordination with behavioral health services to prevent recurrence.

Complications

Complications may include organ damage (e.g., liver or kidney failure), respiratory distress, or cardiovascular instability. Long-term effects can occur if toxicity is severe or treatment is delayed.

Lifestyle & Prevention

Prevention involves secure storage of medications, education on proper dosing, and addressing mental health concerns. Encouraging open communication with healthcare providers and access to support resources can reduce risk.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., severe nausea, confusion, or difficulty breathing) occur. Prompt care is critical to minimize harm and address underlying issues.

Tips for Medical Coders

Document the intent as "intentional self-harm" to justify the use of T39.92. Ensure the unspecified nature of the agent is noted, as the code applies when the specific nonopioid analgesic, antipyretic, or antirheumatic is not identified. Clinical documentation must clearly support the self-harm intent for accurate coding.